MSI1 and central nervous system cancer: The most prominent and significant upregulation of MSI1 is observed in low–grade glioma (LGG) and glioblastoma (GBM), and ovarian (OV) and endometrial cancers of the uterine corpus (UCEC) (Figure 2B,C).